DR REDDYS LABORATORIES LTD — Investor Presentation 2021

Jan 11, 2021

==> picture [468 x 113] intentionally omitted <==

January 11, 2021

Corporate Relationship Department BSE Limited Dalal Street, Fort Mumbai – 400 001 Fax Nos.: 022-22723121 / 22723719 / 22722037 / 22722039

National Stock Exchange of India Ltd. “Exchange Plaza” Bandra-Kurla Complex, Bandra (East), Mumbai – 400 051 Fax Nos.: 022-26598120/ 26598237/ 26598238

Scrip Code: 500124

Scrip Code: DRREDDY-EQ

Dear Sirs,

Sub: Press Release

Please find enclosed a Press Release on “Dr. Reddy's Laboratories to present at the 39th Annual J.P. Morgan Healthcare Conference.”

This is for your information.

With regards,

Digitally signed by SANDEEP PODDAR DN: c=IN, o=Personal, pseudonym=5baa65b04542ac0f9e3878c9d91f0db SANDEEP 36d0548a0, 2.5.4.20=bfda99c592e4dc5b7a2e12970b9505d6d5 1634ab609953e7b6cd73ea7af49394, postalCode=500084, st=TELANGANA, serialNumber=8185d5106ea0d6196f14ae660c09b PODDAR ac334f5ebc1a1790e158f29af33bf208cac, cn=SANDEEP PODDAR Date: 2021.01.11 19:17:40 +05'30' Sandeep Poddar Company Secretary

Encl: As above

CC:- New York Stock Exchange Inc.(Stock Code :RDY) NSE IFSC Ltd

Press Release

==> picture [151 x 50] intentionally omitted <==

	DR. REDDY'S LABORATORIES LTD.8-2-337, Road No. 3, Banjara Hills,Hyderabad - 500034. Telangana, India.			CONTACT
			INVESTOR RELATIONS		MEDIA RELATIONS
			AMIT AGARWAL		APARNA TEKURIaparnatekuri@drreddys.com(PH: +91-40- 49002446)
			amita@drreddys.com
			(PH: +91-40-49002135)

………………………………………………………………………………………………………………………..……………….

Dr. Reddy's Laboratories to present at the 39[th] Annual J.P. Morgan Healthcare Conference

Hyderabad, India, January 11, 2021 For Immediate Release

…..….…………………………………………………………………………………………………………………………………………………………………...

Hyderabad, India and Princeton, NJ, USA. January 11[th] , 2021 — Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) announced that the Company will be presenting at the 39[th] Annual J.P. Morgan Healthcare Conference on Wednesday, 13[th] January, 2021.

Erez Israeli, company’s Chief Executive Officer will present at the Fireside Chat session at 11:00 AM EST [9:30 PM IST].

Weblink to join and listen to the fire side chat is given below: https://jpmorgan.metameetings.net/events/healthcare21/sessions/35274-dr-reddy-slaboratories-ltd/webcast?gpu_only=true&kiosk=true

==> picture [494 x 83] intentionally omitted <==

……………………………………………………………………………………..…………………

About Dr. Reddy’s : Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Dr. Reddy’s operates in markets across the globe. Our major markets include – USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com

…………………………………………………………………………………………………………………………………………………………… Disclaimer : This press release may include statements of future expectations and other forward-looking statements that are based on the management’s current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers’, products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19), and (vii) other risks and uncertainties identified in our public filings with the Securities and Exchange Commission, including those listed under the "Risk Factors" and "Forward-Looking Statements" sections of our Annual Report on Form 20-F for the year ended March 31, 2020. The company assumes no obligation to update any information contained herein.”

Digitally signed by SANDEEP PODDAR DN: c=IN, o=Personal, SANDEEP pseudonym=5baa65b04542ac0f9e3878c9d91f0db36d0548a0, 2.5.4.20=bfda99c592e4dc5b7a2e12970b9505d6d51634ab609 953e7b6cd73ea7af49394, postalCode=500084, st=TELANGANA, serialNumber=8185d5106ea0d6196f14ae660c09bac334f5ebc 1a1790e158f29af33bf208cac, cn=SANDEEP PODDAR PODDAR Date: 2021.01.11 19:18:43 +05'30'